Arkolith/Insider Trading/HALO/Form 4

Ramsay David A

EVP, PRESIDENT, DRUG DELIVERYHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed Jul 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Option exercise(M)10K—$010K
Jun 30, 2026Tax withholding(F)5K$78.27$423K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Grant(A)16K—$016K
Jul 1, 2026Grant(A)40K—$040K
Jun 30, 2026Option exercise(M)10K—$00

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000096) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML